The store will not work correctly when cookies are disabled.
4-(7-oxo-7-(pyrrolidin-1-yl)heptyl)benzoic acid
ID: ALA4552819
PubChem CID: 155556127
Max Phase: Preclinical
Molecular Formula: C18H25NO3
Molecular Weight: 303.40
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)c1ccc(CCCCCCC(=O)N2CCCC2)cc1
Standard InChI: InChI=1S/C18H25NO3/c20-17(19-13-5-6-14-19)8-4-2-1-3-7-15-9-11-16(12-10-15)18(21)22/h9-12H,1-8,13-14H2,(H,21,22)
Standard InChI Key: TZDCXLHGQIPSCY-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
9.9961 -20.0005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7039 -19.5920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4116 -20.0005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2884 -19.5920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5807 -20.0005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8730 -19.5920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1653 -20.0005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4576 -19.5920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7499 -20.0005 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4576 -18.7748 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9999 -19.6666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4531 -20.2739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8617 -20.9817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6610 -20.8117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4090 -20.8188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1159 -21.2273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8246 -20.8187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8220 -19.9973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1145 -19.5924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5364 -21.2280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5375 -22.0452 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2436 -20.8184 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
9 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 9 1 0
3 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 3 1 0
20 21 1 0
20 22 2 0
17 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 303.40 | Molecular Weight (Monoisotopic): 303.1834 | AlogP: 3.50 | #Rotatable Bonds: 8 |
Polar Surface Area: 57.61 | Molecular Species: ACID | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.24 | CX Basic pKa: ┄ | CX LogP: 3.54 | CX LogD: 0.53 |
Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.75 | Np Likeness Score: -0.39 |
References
1. Zhou P, Xiang L, Zhao D, Ren J, Qiu Y, Li Y.. (2019) Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors., 10 (2): [PMID:30931090] [10.1039/C8MD00432C] |